Ono Pharmaceutical Total Liabilities 2010-2024 | OPHLF

Ono Pharmaceutical total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Ono Pharmaceutical Total Liabilities 2010-2024 | OPHLF

Ono Pharmaceutical total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Related Stocks
Company NameMarket
Cap
Zoetis (ZTS)$76.8B
Chugai Pharmaceutical (CHGCY)$66.9B
Takeda Pharmaceutical (TAK)$42.4B
Sandoz Group AG (SDZNY)$20.6B
Merck (MKKGY)$20B
Astellas Pharma (ALPMY)$17.7B
United Therapeutics (UTHR)$16.6B
Summit Therapeutics (SMMT)$16B
Neurocrine Biosciences (NBIX)$15.3B
Shionogi (SGIOY)$12.5B
Orion OYJ (ORINY)$7.5B
Madrigal Pharmaceuticals (MDGL)$7.1B
Stevanato Group S.p.A (STVN)$6.5B
Corcept Therapeutics (CORT)$6.4B
Hikma Pharmaceuticals Plc (HKMPF)$5.9B
Ionis Pharmaceuticals (IONS)$5.2B
Grifols, S.A (GRFS)$4.8B
Crinetics Pharmaceuticals (CRNX)$3.7B
Catalyst Pharmaceuticals (CPRX)$2.9B
Recursion Pharmaceuticals (RXRX)$2.8B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.7B
Centessa Pharmaceuticals (CNTA)$2.2B
Soleno Therapeutics (SLNO)$2.1B
Hypermarcas (HYPMY)$1.9B
NewAmsterdam Pharma (NAMS)$1.9B
Indivior (INDV)$1.7B
BioCryst Pharmaceuticals (BCRX)$1.7B
Evotec AG (EVO)$1.5B
Guardian Pharmacy Services (GRDN)$1.4B
ARS Pharmaceuticals (SPRY)$1.4B